Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novavax Inc (NVAX)

Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,415,914
  • Shares Outstanding, K 162,936
  • Annual Sales, $ 1,123 M
  • Annual Income, $ 440,300 K
  • EBIT $ 453 M
  • EBITDA $ 480 M
  • 60-Month Beta 2.65
  • Price/Sales 1.22
  • Price/Cash Flow 2.39
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 84.23% (+3.67%)
  • Historical Volatility 53.12%
  • IV Percentile 57%
  • IV Rank 15.41%
  • IV High 257.13% on 01/28/26
  • IV Low 52.73% on 06/30/25
  • Expected Move (DTE 7) 0.62 (7.18%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 5,265
  • Volume Avg (30-Day) 10,573
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 253,091
  • Open Int (30-Day) 232,973
  • Expected Range 8.02 to 9.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.30
  • Number of Estimates 4
  • High Estimate $-0.15
  • Low Estimate $-0.46
  • Prior Year $2.93
  • Growth Rate Est. (year over year) -110.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.57 +14.21%
on 04/02/26
10.94 -21.01%
on 03/17/26
-1.44 (-14.29%)
since 03/16/26
3-Month
7.57 +14.21%
on 04/02/26
11.97 -27.82%
on 02/26/26
+0.63 (+7.87%)
since 01/16/26
52-Week
5.80 +48.97%
on 05/09/25
11.97 -27.82%
on 02/26/26
+2.44 (+39.35%)
since 04/16/25

Most Recent Stories

More News
Novavax (NVAX): Buy, Sell, or Hold Post Q4 Earnings?

Novavax (NVAX): Buy, Sell, or Hold Post Q4 Earnings?

NVAX : 8.64 (-0.58%)
3 Reasons NVAX is Risky and 1 Stock to Buy Instead

3 Reasons NVAX is Risky and 1 Stock to Buy Instead

NVAX : 8.64 (-0.58%)
1 Russell 2000 Stock with Exciting Potential and 2 We Avoid

1 Russell 2000 Stock with Exciting Potential and 2 We Avoid

GO : 7.15 (-1.11%)
FCFS : 207.03 (+2.19%)
NVAX : 8.64 (-0.58%)
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know

AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know

AMN : 20.45 (+5.58%)
ABBV : 208.99 (+0.27%)
NVAX : 8.64 (-0.58%)
DVA : 148.13 (+2.46%)
BMY : 58.96 (+1.85%)
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

GAITHERSBURG, Md. , March 30, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development...

NVAX : 8.64 (-0.58%)
Novavax (NVAX) Stock Trades Down, Here Is Why

Novavax (NVAX) Stock Trades Down, Here Is Why

NVAX : 8.64 (-0.58%)
3 Stocks Under $50 That Concern Us

3 Stocks Under $50 That Concern Us

YELP : 27.42 (+1.82%)
NVAX : 8.64 (-0.58%)
FNF : 48.12 (-0.62%)
2 Healthcare Stocks to Target This Week and 1 That Underwhelm

2 Healthcare Stocks to Target This Week and 1 That Underwhelm

HIMS : 26.99 (+11.12%)
NVAX : 8.64 (-0.58%)
DXCM : 61.23 (-0.50%)
3 Profitable Stocks That Concern Us

3 Profitable Stocks That Concern Us

OLED : 99.33 (+0.74%)
NVAX : 8.64 (-0.58%)
AEO : 19.17 (-1.29%)
Why Novavax (NVAX) Shares Are Falling Today

Why Novavax (NVAX) Shares Are Falling Today

NVAX : 8.64 (-0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple...

See More

Key Turning Points

3rd Resistance Point 9.15
2nd Resistance Point 8.97
1st Resistance Point 8.81
Last Price 8.64
1st Support Level 8.47
2nd Support Level 8.29
3rd Support Level 8.13

See More

52-Week High 11.97
Fibonacci 61.8% 9.61
Fibonacci 50% 8.89
Last Price 8.64
Fibonacci 38.2% 8.16
52-Week Low 5.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.